It will be important to ensure that the workup and interventions recommended are judicious, evidence-based, and not prohibitively expensive once these recommendations are introduced on a very broad scale, especially if practicing physicians and payers may feel wary about exercising their judgment and overriding them.

FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!